Literature DB >> 15436440

The chemotherapy of experimental tuberculosis. II. Thiosemicarbazones and analogues in experimental tuberculosis in the mouse.

D HAMRE, J BERNSTEIN, R DONOVICK.   

Abstract

Entities:  

Keywords:  THIOSEMICARBAZONES; TUBERCULOSIS

Mesh：

Substances：

Year:  1950        PMID： 15436440      PMCID： PMC385811          DOI： 10.1128/jb.59.5.675-680.1950

Source DB:  PubMed          Journal:  J Bacteriol        ISSN： 0021-9193            Impact factor:   3.490


× No keyword cloud information.
  1 in total

1.  Cytological changes in Escherichia coli produced by infection with phage T2.

Authors:  R G E MURRAY; D H GILLEN; F C HEAGY
Journal:  J Bacteriol       Date:  1950-05       Impact factor: 3.490
  1 in total
  6 in total

1.  Chemical constitution and anti-tuberculous activity. IV. Thiosemicarbazones and related compounds.

Authors:  J CYMERMAN-CRAIG; S D RUBBO; J W LODER; B J PIERSON
Journal:  Br J Exp Pathol       Date:  1956-02

2.  Clinical trial of T.B.3 in surgical tuberculosis.

Authors:  J H MAYER; P G LAING
Journal:  Br Med J       Date:  1953-01-24

3.  Antifungal Activity of Some Thiosemicarbazones and Their Copper Complexes.

Authors:  B G Benns; B A Gingras; C H Bayley
Journal:  Appl Microbiol       Date:  1960-11

4.  Identification of the molecular target of small molecule inhibitors of HDL receptor SR-BI activity.

Authors:  Thomas J F Nieland; Jared T Shaw; Firoz A Jaipuri; Jay L Duffner; Angela N Koehler; Sotirios Banakos; Vassilis I Zannis; Tomas Kirchhausen; Monty Krieger
Journal:  Biochemistry       Date:  2007-12-08       Impact factor: 3.162

5.  Tuberculostatic activity of some 4-arylthiosemicarbazides and 4-arylthiosemicarbazones.

Authors:  M TISLER
Journal:  Experientia       Date:  1956-07-15

6.  In vitro assessment of the role of DpC in the treatment of head and neck squamous cell carcinoma.

Authors:  Ye-Xing Xu; Man-Li Zeng; Di Yu; Jie Ren; Fen Li; Anyuan Zheng; Yong-Ping Wang; Chen Chen; Ze-Zhang Tao
Journal:  Oncol Lett       Date:  2018-03-15       Impact factor: 2.967
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.